Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

T. C. Lynn; R. P. Hsieh; K. T. Lin; M. C. Shen; D. S. Chen; C. H. Wang; C. H. Liu; J. H. Wang; M. Y. Lai; M. F. Liou; M. R. Hsieh; C. Y. Chuang; R. Ting; Jacqueline Whang-Peng

Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

T. C. Lynn, R. P. Hsieh, K. T. Lin, M. C. Shen, D. S. Chen, C. H. Wang, C. H. Liu, J. H. Wang, M. Y. Lai, M. F. Liou, M. R. Hsieh, C. Y. Chuang, R. Ting, Jacqueline Whang-Peng

Research output: Contribution to journal › Article › peer-review

Abstract

A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

Original language	English
Pages (from-to)	172-176
Number of pages	5
Journal	Zhonghua minguo weishengwu ji mianyixue zazhi
Volume	17
Issue number	3
Publication status	Published - Aug 1 1984
Externally published	Yes

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{d4509a3fec7d47ea83474e3000c229ce,

title = "Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.",

abstract = "A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.",

author = "Lynn, {T. C.} and Hsieh, {R. P.} and Lin, {K. T.} and Shen, {M. C.} and Chen, {D. S.} and Wang, {C. H.} and Liu, {C. H.} and Wang, {J. H.} and Lai, {M. Y.} and Liou, {M. F.} and Hsieh, {M. R.} and Chuang, {C. Y.} and R. Ting and Jacqueline Whang-Peng",

year = "1984",

month = aug,

day = "1",

language = "English",

volume = "17",

pages = "172--176",

journal = "Zhonghua minguo weishengwu ji mianyixue zazhi",

issn = "0253-2662",

publisher = "Lippincott Williams & Wilkins Asia",

number = "3",

}

TY - JOUR

T1 - Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics

T2 - a preliminary report.

AU - Lynn, T. C.

AU - Hsieh, R. P.

AU - Lin, K. T.

AU - Shen, M. C.

AU - Chen, D. S.

AU - Wang, C. H.

AU - Liu, C. H.

AU - Wang, J. H.

AU - Lai, M. Y.

AU - Liou, M. F.

AU - Hsieh, M. R.

AU - Chuang, C. Y.

AU - Ting, R.

AU - Whang-Peng, Jacqueline

PY - 1984/8/1

Y1 - 1984/8/1

N2 - A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

AB - A total of 132 sera were studied for anti-HTLV antibodies using the Biotech ELISA test. Among the HTL group, two were, one, and the other two (+/-). Among 23 hemophiliacs one was. None of the lympho- and myelo-proliferative disorders, chronic uremics and normal controls showed positive results. Our results show that the ELISA anti-HTLV test is quite specific for HTL and related disorders, but the antibody titers may be low in some cases in the late stage. The significance of frequent high ELISA readings in hepatomas and NPCs awaits for further studies. The occurrence of one hemophiliac with definite positive anti-HTLV calls for a routine screening of the blood preparations for HTLV.

UR - http://www.scopus.com/inward/record.url?scp=0021476276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021476276&partnerID=8YFLogxK

M3 - Article

C2 - 6096089

AN - SCOPUS:0021476276

SN - 0253-2662

VL - 17

SP - 172

EP - 176

JO - Zhonghua minguo weishengwu ji mianyixue zazhi

JF - Zhonghua minguo weishengwu ji mianyixue zazhi

IS - 3

ER -

Anti-HTLV antibodies in cancer patients, hemophiliacs and uremics: a preliminary report.

Abstract

ASJC Scopus subject areas

UN SDGs

Other files and links

Fingerprint

Cite this